![ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC](https://www.cdc.gov/vaccines/acip/recs/grade/images/novavax-04-adult-schedule.png?_=39257)
ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC
![CDC on X: "CDC recommends Novavax's non-mRNA booster for people ages 18+, for certain situations. This includes those unable or unwilling to receive mRNA #COVID19 vaccines. The Novavax COVID-19 booster targets the CDC on X: "CDC recommends Novavax's non-mRNA booster for people ages 18+, for certain situations. This includes those unable or unwilling to receive mRNA #COVID19 vaccines. The Novavax COVID-19 booster targets the](https://pbs.twimg.com/media/FfhW90pX0AARJXn.png)
CDC on X: "CDC recommends Novavax's non-mRNA booster for people ages 18+, for certain situations. This includes those unable or unwilling to receive mRNA #COVID19 vaccines. The Novavax COVID-19 booster targets the
![Major delay in Australian government's Novavax deal, with 51m doses not expected until 2022 | Australian politics | The Guardian Major delay in Australian government's Novavax deal, with 51m doses not expected until 2022 | Australian politics | The Guardian](https://i.guim.co.uk/img/media/7a38c3e8202ca8a318643e4972ee5848af1c92cc/0_161_3500_2100/master/3500.jpg?width=1200&height=1200&quality=85&auto=format&fit=crop&s=9046ec148ca8ef84d93a6a5fe3817e49)
Major delay in Australian government's Novavax deal, with 51m doses not expected until 2022 | Australian politics | The Guardian
![Novavax Expects Its Updated COVID-19 Vaccine Candidate to Work on Circulating Variants | Health News | U.S. News Novavax Expects Its Updated COVID-19 Vaccine Candidate to Work on Circulating Variants | Health News | U.S. News](https://www.usnews.com/dims4/USNEWS/baecc6a/2147483647/thumbnail/970x647/quality/85/?url=https%3A%2F%2Fwww.usnews.com%2Fcmsmedia%2F3e%2F9a%2F11abc3cc4780aa273407554307d4%2Fap22159814230246.jpg)
Novavax Expects Its Updated COVID-19 Vaccine Candidate to Work on Circulating Variants | Health News | U.S. News
![ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC](https://www.cdc.gov/vaccines/acip/recs/grade/images/novavax-02-adult-schedule.png?_=39252)